Literature DB >> 24737488

Isolation of dendritic-cell-like S100β-positive cells in rat anterior pituitary gland.

Kotaro Horiguchi1, Ken Fujiwara, Saishu Yoshida, Masashi Higuchi, Takehiro Tsukada, Naoko Kanno, Takashi Yashiro, Kozue Tateno, Shunji Osako, Takako Kato, Yukio Kato.   

Abstract

S100β-protein-positive cells in the anterior pituitary gland appear to possess multifunctional properties. Because of their pleiotropic features, S100β-positive cells are assumed to be of a heterogeneous or even a non-pituitary origin. The observation of various markers has allowed these cells to be classified into populations such as stem/progenitor cells, epithelial cells, astrocytes and dendritic cells. The isolation and characterization of each heterogeneous population is a prerequisite for clarifying the functional character and origin of the cells. We attempt to isolate two of the subpopulations of S100β-positive cells from the anterior lobe. First, from transgenic rats that express green fluorescent protein (GFP) driven by the S100β protein promoter, we fractionate GFP-positive cells with a cell sorter and culture them so that they can interact with laminin, a component of the extracellular matrix. We observe that one morphological type of GFP-positive cells possesses extended cytoplasmic processes and shows high adhesiveness to laminin (process type), whereas the other is round in shape and exhibits low adherence to laminin (round type). We successfully isolate cells of the round type from the cultured GFP-positive cells by taking advantage of their low affinity to laminin and then measure mRNA levels of the two cell types by real-time polymerase chain reaction. The resultant data show that the process type expresses vimentin (mesenchymal cell marker) and glial fibrillary acidic protein (astrocyte marker). The round type expresses dendritic cell markers, CD11b and interleukin-6. Thus, we found a method for isolating dendritic-cell-like S100β-positive cells by means of their property of adhering to laminin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24737488     DOI: 10.1007/s00441-014-1817-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  5 in total

1.  S100a4-Cre-mediated deletion of Patched1 causes hypogonadotropic hypogonadism: role of pituitary hematopoietic cells in endocrine regulation.

Authors:  Yi Athena Ren; Teresa Monkkonen; Michael T Lewis; Daniel J Bernard; Helen C Christian; Carolina J Jorgez; Joshua A Moore; John D Landua; Haelee M Chin; Weiqin Chen; Swarnima Singh; Ik Sun Kim; Xiang Hf Zhang; Yan Xia; Kevin J Phillips; Harry MacKay; Robert A Waterland; M Cecilia Ljungberg; Pradip K Saha; Sean M Hartig; Tatiana Fiordelisio Coll; JoAnne S Richards
Journal:  JCI Insight       Date:  2019-07-02

2.  CD9-positive cells in the intermediate lobe migrate into the anterior lobe to supply endocrine cells.

Authors:  K Horiguchi; K Fujiwara; T Tsukada; T Nakakura; S Yoshida; R Hasegawa; S Takigami; S Ohsako
Journal:  Histochem Cell Biol       Date:  2021-06-29       Impact factor: 4.304

Review 3.  Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.

Authors:  Juan Pedro Martinez-Barbera; Cynthia L Andoniadou
Journal:  Stem Cells       Date:  2016-01-13       Impact factor: 6.277

4.  S100β-Positive Cells of Mesenchymal Origin Reside in the Anterior Lobe of the Embryonic Pituitary Gland.

Authors:  Kotaro Horiguchi; Hideji Yako; Saishu Yoshida; Ken Fujiwara; Takehiro Tsukada; Naoko Kanno; Hiroki Ueharu; Hiroto Nishihara; Takako Kato; Takashi Yashiro; Yukio Kato
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

5.  Clinical Heterogeneity of Acquired Idiopathic Isolated Adrenocorticotropic Hormone Deficiency.

Authors:  Yasunori Fujita; Hironori Bando; Genzo Iguchi; Keiji Iida; Hitoshi Nishizawa; Keitaro Kanie; Kenichi Yoshida; Ryusaku Matsumoto; Kentaro Suda; Hidenori Fukuoka; Wataru Ogawa; Yutaka Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-19       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.